SerenaGroup Monroeville
Monroeville, Pennsylvania, 15146, United States
NCT Number: NCT07646938
This is a prospective, clinical evaluation of the MolecuLightDX+ with OxySight Module in wound care.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Monroeville, Pennsylvania, 15146, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MolecuLightDX+ with OxySight Module is an imaging device intended to acquire fluorescence, oxygenation, thermal, and measurement images of wounds.
Time frame: up to 1 month
Evaluate the feasibility of using tissue oxygenation (StO2) to further inform fluorescence-guided debridement.
Time frame: up to 1 month
Observe and quantify changes in tissue oxygenation (StO2) from before to immediately after fluorescence-guided debridement.
MolecuLight Inc.
Industry
A Prospective, Clinical Evaluation of the MolecuLightDX+ With OxySight Module to Observe the Clinical Utility of Tissue Oxygenation, Bacterial Fluorescence and Thermal Signatures
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06682923
Wound of Skin, Wounds
Hamilton, Ontario, Canada
View Trial DetailsNCT06761690
Wound Heal, Wounds
Bursa, Nilüfer, Turkey (Türkiye)
View Trial DetailsNCT05047809
Actinomycetales Infections, Bacterial Infections
Taoyuan City, Taiwan
View Trial DetailsNCT06083740
Burns, Wounds
Salzburg, Austria
View Trial Details